BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 199940)

  • 1. [Selection of patients with breast cancer with regard to endocrine therapy].
    Cikes M; Pettavel J
    Schweiz Med Wochenschr; 1977 Nov; 107(46):1645-55. PubMed ID: 199940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer of the breast. Endocrine and hormonal therapy.
    Kardinal CG; Donegan WL
    Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormone receptors in the management of human breast cancer.
    Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
    Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
    Osborne CK; McGuire WL
    Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormones and tumor therapy: the rational basis of endocrine therapy in breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):459-63. PubMed ID: 6297173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
    Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
    Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for cancer of the breast. Current status of steroid hormone receptors.
    Osborne CK; McGuire WL
    West J Med; 1979 May; 130(5):401-7. PubMed ID: 516664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of tissue estrogen receptors in the strategy of breast cancer treatment.
    Heuson JC; Leclercq G
    Arch Geschwulstforsch; 1975; 45(5):417-22. PubMed ID: 174515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor: a valid test for selection of breast cancer patients for endocrine ablation.
    Leung BS; Fletcher WS; Krippaehne WW
    Surg Forum; 1973; 24():125-7. PubMed ID: 4142813
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    Cancer Res; 1979 Jun; 39(6 Pt 1):1973-9. PubMed ID: 445396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are endocrine receptors determining factors for the prognosis of carcinoma of the breast?].
    De Lena M; Paradiso A; Maiello E
    Ric Clin Lab; 1985; 15 Suppl 2():63-71. PubMed ID: 3006215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal therapy of the advanced breast cancer ].
    Gürtler R; Matthes ML; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise selection of breast cancer patients with bone metastasis for endocrine ablation.
    Minton JP
    Surgery; 1976 Oct; 80(4):513-7. PubMed ID: 184557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.